Greg J. Divis

Greg J. Divis has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Avadel Pharmaceuticals PLC and KV Pharmaceutical Co /DE/. Over a trading history stretching from 18 July 2008 to 15 November 2019, the count stands at 7 filings.

Purchases make up the whole of the open-market record (3 purchases, €253k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants and 1 option exercise. In 2019 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €83k and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 19 November 2019: an open-market purchase of €88k, in Avadel Pharmaceuticals PLC. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.